CRP and COVID-19: In addition, C‐reactive protein (CRP) level could be used in the early pneumonia diagnosis3 because it increases in 75%–93% of COVID‐19 cases and therefore could be used along with other biomarkers such as lymphocyte count to assess lung lesions and the severity of COVID‐19 disease.4